A detailed history of Two Sigma Investments, LP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 98,041 shares of PASG stock, worth $63,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,041
Previous 103,854 5.6%
Holding current value
$63,726
Previous $82,000 17.07%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.64 - $1.0 $3,720 - $5,813
-5,813 Reduced 5.6%
98,041 $68,000
Q2 2024

Aug 14, 2024

SELL
$0.79 - $1.58 $76,866 - $153,732
-97,299 Reduced 48.37%
103,854 $82,000
Q4 2023

Feb 14, 2024

SELL
$0.6 - $1.01 $16,260 - $27,372
-27,101 Reduced 11.87%
201,153 $203,000
Q3 2023

Nov 14, 2023

SELL
$0.66 - $1.01 $20,856 - $31,916
-31,600 Reduced 12.16%
228,254 $150,000
Q2 2023

Aug 14, 2023

SELL
$0.82 - $1.19 $23,839 - $34,595
-29,072 Reduced 10.06%
259,854 $244,000
Q1 2023

May 15, 2023

SELL
$0.96 - $1.88 $62,877 - $123,134
-65,497 Reduced 18.48%
288,926 $277,000
Q4 2022

Feb 14, 2023

SELL
$1.06 - $1.48 $33,270 - $46,452
-31,387 Reduced 8.14%
354,423 $489,000
Q3 2022

Nov 14, 2022

SELL
$1.22 - $2.48 $4,498 - $9,143
-3,687 Reduced 0.95%
385,810 $482,000
Q2 2022

Aug 15, 2022

SELL
$1.63 - $3.46 $201,702 - $428,154
-123,744 Reduced 24.11%
389,497 $919,000
Q1 2022

May 16, 2022

BUY
$2.66 - $6.49 $225,145 - $549,320
84,641 Added 19.75%
513,241 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$6.24 - $10.2 $1.39 Million - $2.27 Million
222,960 Added 108.42%
428,600 $2.72 Million
Q3 2021

Nov 15, 2021

BUY
$9.73 - $15.52 $1.13 Million - $1.81 Million
116,336 Added 130.27%
205,640 $2.05 Million
Q2 2021

Aug 16, 2021

BUY
$12.44 - $19.45 $932,900 - $1.46 Million
74,992 Added 523.98%
89,304 $1.18 Million
Q1 2021

May 17, 2021

BUY
$16.24 - $29.83 $232,426 - $426,926
14,312 New
14,312 $250,000

Others Institutions Holding PASG

About Passage BIO, Inc.


  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $35.4M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.